These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21018391)

  • 21. [Cutaneous leishmaniasis: ulcerous, lupoid, verruciform of zoniform disposition: rapid recovery due to glucatime].
    LAUGIER P; LEVILLAIN R; PAGEAUT G; LENYS R; BIA M
    Bull Soc Fr Dermatol Syphiligr; 1959; 5():822-4. PubMed ID: 13848532
    [No Abstract]   [Full Text] [Related]  

  • 22. Sodium stibogluconate in the treatment of kalaazar; report on the treatment of eight cases and the appearance of probable drug reactions.
    MAEGRAITH B; BRUNDRETT JC
    Ann Trop Med Parasitol; 1947 May; 41(1):118-28. PubMed ID: 20249296
    [No Abstract]   [Full Text] [Related]  

  • 23. [A case of kala-azar treated with a new antimony].
    NAUSSAC ; PELLERAT ; GONNET L
    Lyon Med; 1947 May; 177(20):334-9. PubMed ID: 20268746
    [No Abstract]   [Full Text] [Related]  

  • 24. Difference in responses of Leishmania canis and Leishmania donovani toward ureastibamine.
    HO EA; SOONG HY; YUAN IC
    Med Abstr; 1945 Oct; 63A():207-12. PubMed ID: 20997131
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of infantile kala-azar].
    SALA GINABREDA JM; RIBA BRUFAROLAS P
    Rev Esp Pediatr; 1952; 8(2):219-25. PubMed ID: 12983816
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of sodium antimony gluconate in mass treatment of kala-azar by the rate of disappearance of Leishman-Donovan bodies.
    HO EA; TAO CY; SUNG SJ
    Chin Med J; 1952; 70(5-6):243-52. PubMed ID: 13127087
    [No Abstract]   [Full Text] [Related]  

  • 27. Epidemiological, clinical and therapeutic features of Bihar kala-azar (including post kala-azar dermal leishmaniasis).
    Thakur CP
    Trans R Soc Trop Med Hyg; 1984; 78(3):391-8. PubMed ID: 6087515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of infantile visceral leishmaniasis with solusurmin according to material of the parasitological department of the Tashkent City Sanitary-Epidemiological Station].
    MIKHAILOV VG; STARTSEVA MA
    Med Parazitol (Mosk); 1961; 30():563-7. PubMed ID: 14473694
    [No Abstract]   [Full Text] [Related]  

  • 29. [Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases].
    Bourée P; Anciaux ML; Taugourdeau P
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):607-10. PubMed ID: 3003657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Our experience in the treatment of kala-azar].
    de YTURRIAGA E; GONZALEZ BOTELLA S
    Acta Pediatr Esp; 1950 May; 8(89):569-76. PubMed ID: 15418997
    [No Abstract]   [Full Text] [Related]  

  • 31. KALA AZAR IN LEBANON. REVIEW OF 72 CASES.
    BITAR J; NACHMAN H
    J Med Liban; 1964; 17():257-68. PubMed ID: 14252819
    [No Abstract]   [Full Text] [Related]  

  • 32. Sudanese mucosal leishmaniasis: epidemiology, clinical features, diagnosis, immune responses and treatment.
    el-Hassan AM; Meredith SE; Yagi HI; Khalil EA; Ghalib HW; Abbas K; Zijlstra EE; Kroon CC; Schoone GJ; Ismail A
    Trans R Soc Trop Med Hyg; 1995; 89(6):647-52. PubMed ID: 8594683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies in Mediterranean leishmaniasis. 3. The leishmanin skin test in kala-azar.
    Pampiglione S; Manson-Bahr PE; La Placa M; Borgatti MA; Musumeci S
    Trans R Soc Trop Med Hyg; 1975; 69(1):60-8. PubMed ID: 1145719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis of kala-azar. II. Study of Montenegro's test and detection of Leishmania in skin material from patients with kala-azar, before and after antimony treatment].
    Mayrink W; Magalhàes PA; Batista SM; da Costa CA
    Rev Inst Med Trop Sao Paulo; 1971; 13(4):268-71. PubMed ID: 5132387
    [No Abstract]   [Full Text] [Related]  

  • 35. [Three observations of kala azar cured by glucantime (2168-RP)].
    LEBON J; FABREGOULE M; AMOROS F
    Cah Med Union Fr; 1948 Dec; 3(25):761-6. PubMed ID: 18112444
    [No Abstract]   [Full Text] [Related]  

  • 36. THE HUMAN TRYPANOSOMATIDAE. III. LEISHMANIASIS: KALA-AZAR.
    CAHILL KM
    N Y State J Med; 1963 Dec; 63():3405-9. PubMed ID: 14083434
    [No Abstract]   [Full Text] [Related]  

  • 37. Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis.
    Zijlstra EE; Khalil EA; Kager PA; El-Hassan AM
    Br J Dermatol; 2000 Jul; 143(1):136-43. PubMed ID: 10886148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Two cases of kala-azar treated with glucantime].
    MATOS J; VELASCO JA
    Acta Pediatr Esp; 1955 Nov; 13(155):959-63. PubMed ID: 13301754
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment for kala-azar: methods and results at the Infants' Clinic in Marseille].
    GIRAUD P; BERNARD R; ORSINI A
    Sem Hop; 1956 Jul 10-14; 32(42-43/6):2431-4. PubMed ID: 13351757
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatitis B and C viral infections in Indian kala-azar patients receiving injectable anti-leishmanial drugs: a community-based study.
    Singh S ; Kumar J; Singh R; Dwivedi SN
    Int J Infect Dis; 2000; 4(4):203-8. PubMed ID: 11231183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.